Fact-checked by Grok 2 weeks ago

ACTH stimulation test

The ACTH stimulation test, also known as the cosyntropin stimulation test, is a dynamic endocrine evaluation that assesses the adrenal glands' ability to produce cortisol in response to synthetic adrenocorticotropic hormone (ACTH), aiding in the diagnosis of adrenal insufficiency (AI).^[1] This test is particularly valuable for confirming primary AI (due to adrenal gland damage), secondary AI (due to pituitary dysfunction), or tertiary AI (due to hypothalamic issues), as well as evaluating non-classic congenital adrenal hyperplasia in select cases.^[1] Adrenal insufficiency is a potentially life-threatening condition characterized by inadequate cortisol production, which can lead to symptoms such as fatigue, hypotension, and electrolyte imbalances if untreated.^[2] The standard procedure involves administering 250 micrograms (mcg) of cosyntropin—a synthetic analog of ACTH—via intravenous (IV) or intramuscular (IM) injection, followed by serial measurements of serum cortisol levels.^[2] Baseline cortisol is drawn immediately before administration, with additional samples collected at 30 and 60 minutes post-injection to capture the peak response; the test is typically performed in the morning (between 6-9 AM) when endogenous cortisol levels are highest.^[2] Preparation may include withholding certain medications like corticosteroids that could suppress the hypothalamic-pituitary-adrenal (HPA) axis, though recent glucocorticoid use is a relative contraindication due to risk of false results.^[1] The test is generally safe, with rare risks including allergic reactions to cosyntropin or transient facial flushing.^[1] Interpretation relies on the post-stimulation cortisol peak: a value of 18 mcg/dL (500 nmol/L) or higher effectively excludes AI, while a peak below 14 mcg/dL (390 nmol/L) confirms the diagnosis, with intermediate values (14-18 mcg/dL) requiring clinical correlation and possibly additional testing like dehydroepiandrosterone sulfate (DHEAS) levels.^[2] Plasma ACTH levels measured alongside can differentiate primary AI (elevated ACTH) from central causes (low or normal ACTH).^[1] Although a low-dose variant (1 mcg cosyntropin) has been proposed for detecting subtle secondary AI, it is not routinely recommended due to issues with availability, precision, and validation.^[2] Overall, the ACTH stimulation test serves as the gold standard for AI diagnosis when baseline cortisol is indeterminate, guiding timely glucocorticoid replacement therapy to prevent adrenal crisis.^[1]

Background and Purpose

Definition and Overview

The ACTH stimulation test is a diagnostic procedure used to evaluate the function of the adrenal glands by measuring serum cortisol levels before and after the administration of synthetic adrenocorticotropic hormone (ACTH), typically cosyntropin.^[1] This test assesses the integrity of the hypothalamic-pituitary-adrenal (HPA) axis, which regulates stress responses and cortisol production.^[3] It is particularly valuable for diagnosing adrenal insufficiency, a condition where the adrenal glands fail to produce adequate cortisol.^[4] In the HPA axis, corticotropin-releasing hormone (CRH) from the hypothalamus stimulates the anterior pituitary gland to secrete ACTH, a peptide hormone derived from pro-opiomelanocortin (POMC). ACTH binds to melanocortin-2 receptors on the adrenal cortex, primarily the zona fasciculata, activating adenylyl cyclase and increasing cyclic AMP levels, which promotes cortisol synthesis and release. Cortisol then exerts negative feedback on the hypothalamus and pituitary to maintain homeostasis. The stimulation test mimics this physiological pathway by providing exogenous ACTH to provoke a cortisol response, thereby distinguishing between primary adrenal failure (high endogenous ACTH, poor response) and secondary or tertiary deficiencies (low endogenous ACTH).^[3] A simplified diagram of the HPA axis depicts the hypothalamus at the top releasing CRH to the pituitary, which outputs ACTH to the adrenal glands at the base, with cortisol looping back upward for feedback inhibition.^[3] The test's historical development began in the 1940s with initial descriptions using hog pituitary extracts to assess adrenal response via the fall in eosinophil count.^[5] It was refined in the 1950s using purified porcine ACTH and direct measurement of plasma cortisol for greater accuracy.^[5] By the 1960s, the introduction of synthetic cosyntropin—a 24-amino-acid analog of human ACTH—standardized the procedure and minimized risks like allergic reactions associated with animal-derived preparations, leading to its widespread adoption.^[5] This evolution improved reliability and safety in clinical practice.^[1]

Clinical Indications

The ACTH stimulation test is primarily indicated for the diagnosis of primary adrenal insufficiency, also known as Addison's disease, where the adrenal glands fail to produce adequate cortisol despite stimulation by adrenocorticotropic hormone (ACTH).^[6] It serves as the gold standard confirmatory test when clinical suspicion arises from symptoms such as fatigue, weight loss, hypotension, or electrolyte imbalances like hyponatremia, particularly in acutely ill patients.^[7]^[2] The test is also used to diagnose secondary adrenal insufficiency due to pituitary disorders, where insufficient ACTH production leads to adrenal atrophy, and to differentiate it from primary forms by assessing cortisol response alongside baseline ACTH levels.^[2]^[8] Additional applications include postoperative assessment of adrenal function and autonomy after treatment for Cushing's syndrome, such as adrenal tumor resection.^[9] The test is employed to assess hypothalamic-pituitary-adrenal (HPA) axis recovery following adrenalectomy for conditions like Cushing's or subclinical hypercortisolism, as well as during glucocorticoid withdrawal after prolonged exogenous steroid use, which can suppress endogenous cortisol production; as per the 2024 joint Endocrine Society and European Society of Endocrinology guideline on glucocorticoid-induced adrenal insufficiency, dynamic testing like the ACTH stimulation test should be used cautiously in selected cases.^[10]^[11]^[12] In critical illness scenarios, such as sepsis, it has been used to screen for critical illness-related corticosteroid insufficiency (CIRCI), though results must be interpreted cautiously due to altered protein binding and assay variability; however, its utility is controversial, and recent guidelines (as of 2022) recommend against using it to identify patients who should receive glucocorticoids in septic shock.^[13]^[14]^[15] Endocrine Society guidelines from 2016 recommend the test for confirmatory diagnosis in suspected primary adrenal insufficiency, with ongoing emphasis in recent updates and reviews (up to 2024) on early application in cases of unexplained hyponatremia or shock to prevent adrenal crisis.^[6]^[2] As a screening tool, it is not optimal for tertiary adrenal insufficiency (hypothalamic causes), where the HPA axis disruption may not yet manifest as adrenal unresponsiveness, potentially yielding false negatives.^[2]^[16] It is preferred over the insulin tolerance test due to greater safety, avoiding risks like hypoglycemia, while providing a reliable alternative for most patients.^[17]^[18]

Procedure

Patient Preparation

Patients undergoing the ACTH stimulation test should undergo specific preparations to minimize factors that could interfere with accurate cortisol measurement and ensure safety. Prior to the test, healthcare providers typically review the patient's medication history; withhold the morning dose of short-acting glucocorticoids (e.g., hydrocortisone) if clinically feasible, resuming after the test, as recent or ongoing glucocorticoid use is a relative contraindication due to potential suppression of the hypothalamic-pituitary-adrenal (HPA) axis.^[2] Similarly, estrogen-containing medications, which increase cortisol-binding globulin (CBG) levels and may lead to falsely elevated total cortisol readings, should be discontinued 4-6 weeks beforehand if possible.^[19] The test is generally scheduled for the morning to align with the natural diurnal rhythm of cortisol secretion, though it can be performed at any time for diagnostic purposes.^[2] No fasting is required, but patients are instructed to avoid physical or emotional stress on the day of the test, as stress can transiently elevate cortisol levels and confound results. Informed consent is obtained after explaining the test's purpose in evaluating adrenal function, the procedural steps involving an IV injection of cosyntropin, and potential minor risks such as injection-site reactions. Patients are also screened for allergies to cosyntropin or related compounds to prevent adverse reactions. In pregnant individuals, elevated CBG levels increase total cortisol measurements, requiring adjusted diagnostic cutoffs (e.g., subnormal basal cortisol ≤3 mcg/dL is diagnostic) or alternatives like salivary cortisol or free cortisol assays for accurate interpretation.^[2] In cases of recent acute illness, the test may be postponed to allow recovery, as illness can alter HPA axis dynamics and affect cortisol responsiveness.

Test Administration

The ACTH stimulation test is typically performed in an outpatient setting and lasts approximately 1 hour, during which vital signs are monitored to ensure patient safety.^[20]^[21] The standard protocol begins with the collection of a baseline venous blood sample to measure serum cortisol levels, followed immediately by the intravenous (IV) or intramuscular (IM) administration of 250 micrograms (mcg) of cosyntropin, a synthetic analog of adrenocorticotropic hormone (ACTH).^[1]^[2] Additional venous blood samples are then drawn at 30 minutes and 60 minutes post-injection to assess the cortisol response.^[1]^[20] Serum cortisol concentrations from these samples are measured using immunoassays, such as electrochemiluminescence assays, or liquid chromatography-tandem mass spectrometry (LC-MS/MS) for higher specificity, depending on the laboratory protocol.^[22]^[23] A low-dose variant of the test, used for more sensitive detection of mild secondary adrenal insufficiency, involves the IV administration of 1 mcg of cosyntropin instead of the standard dose, with cortisol measurements at 20 and 30 minutes post-administration.^[24]

Variants of the Test

The standard ACTH stimulation test employs a high-dose (250 mcg) of synthetic cosyntropin intravenously or intramuscularly to screen for primary adrenal insufficiency, as this dose maximally stimulates the adrenal cortex in most cases.^[25] In contrast, the low-dose variant uses 1 mcg of cosyntropin, which more closely mimics physiological ACTH levels and demonstrates higher sensitivity for detecting subtle secondary adrenal insufficiency, particularly in cases of mild pituitary dysfunction, according to studies evaluating diagnostic accuracy in the early 2020s.^[26] The low-dose protocol typically involves baseline cortisol measurement followed by post-stimulation samples at 20 and 30 minutes, offering improved specificity over the high-dose test in non-critically ill patients without altering the overall procedural framework.^[25] Combined tests integrate plasma ACTH level measurements with cortisol responses during stimulation to better assess pituitary-adrenal axis integrity, especially for evaluating secondary causes where basal ACTH is low.^[27] For depot formulations, a prolonged infusion variant administers cosyntropin or tetracosactrin depot intramuscularly over up to 48 hours to provoke a sustained adrenal response, useful in confirming borderline or atrophied adrenal function unresponsive to short-term stimulation.^[28] An aldosterone-specific variant of the ACTH stimulation test measures plasma aldosterone alongside cortisol after cosyntropin administration to differentiate primary aldosteronism subtypes, as exaggerated aldosterone responses can indicate adenoma versus hyperplasia.^[29] This adaptation leverages ACTH's role in modulating aldosterone secretion via melanocortin receptors.^[26] Historically, early variants utilized natural porcine ACTH extracts, but these were discontinued in the 1970s due to frequent anaphylactic reactions stemming from immunogenicity, paving the way for safer synthetic analogs like cosyntropin.^[30]

Interpretation of Results

Normal Cortisol Response

In healthy individuals, the ACTH stimulation test evaluates the adrenal glands' capacity to produce cortisol in response to synthetic ACTH (cosyntropin). Baseline serum cortisol levels, typically measured in the morning between 8:00 and 9:00 AM, range from 5 to 25 mcg/dL (138 to 690 nmol/L) in adults, reflecting the normal diurnal rhythm with peak secretion occurring shortly after awakening. This range can vary slightly by laboratory assay method, such as immunoassay or mass spectrometry, which may influence absolute values but not the relative response dynamics.^[31]^[32] Following intravenous or intramuscular administration of 250 mcg cosyntropin, a normal response involves a peak cortisol level of at least 15 mcg/dL (414 nmol/L) or higher at 30 or 60 minutes post-stimulation, depending on the assay method (traditional cutoff 18 mcg/dL or 500 nmol/L; modern assays often use 14-15 mcg/dL to exclude adrenal insufficiency).^[33]^[34]^[35] This threshold, established through clinical guidelines and validated in large cohorts, confirms intact adrenal reserve and hypothalamic-pituitary-adrenal axis function. Cutoffs are assay-dependent; recent guidelines (as of 2021) recommend 14-15 mcg/dL for many modern assays to reduce false positives.^[35] The 30-minute sample often captures the maximal response, though both time points are assessed to ensure reliability.^[35] Reference ranges for normal responses are lab-specific and may require adjustments for age and pediatric populations, where cortisol peaks can be higher—up to 20-25 mcg/dL in younger children due to developmental differences in adrenal sensitivity.^[36] Testing is preferably conducted in the morning to align with circadian peaks and avoid potential blunting of the response in the afternoon, when baseline cortisol is naturally lower (3-10 mcg/dL).^[20] Factors such as recent stress, medications, or assay calibration can subtly affect interpretation, emphasizing the need for standardized protocols.^[2]

Abnormal Responses and Diagnoses

In primary adrenal insufficiency, also known as Addison's disease, the ACTH stimulation test typically reveals a flat cortisol response, with a peak cortisol level below 15 mcg/dL (414 nmol/L) at 30 or 60 minutes post-stimulation (traditional below 18 mcg/dL).^[37]^[1]^[35] This subnormal response confirms adrenal gland damage or dysfunction, often due to autoimmune destruction (as in autoimmune adrenalitis), infections such as tuberculosis, or other causes like hemorrhage or metastases, and is accompanied by elevated baseline plasma ACTH levels greater than 100 pg/mL to distinguish it from central causes.^[37]^[38] Secondary adrenal insufficiency, resulting from pituitary gland failure to produce adequate ACTH, shows a subnormal cortisol response with peak below 15 mcg/dL (414 nmol/L) in long-standing cases (traditional below 18 mcg/dL), indicating adrenal unresponsiveness due to chronic ACTH deficiency, with low or inappropriately normal baseline ACTH levels (often <10 pg/mL).^[20]^[39]^[2] In recent cases, baseline cortisol may be normal, but the peak response remains inadequate. Common etiologies include pituitary tumors, surgical resection, radiation, or Sheehan's syndrome (postpartum pituitary necrosis).^[20]^[38] Tertiary adrenal insufficiency, arising from hypothalamic dysfunction leading to reduced corticotropin-releasing hormone (CRH) and subsequent low ACTH, produces a response pattern similar to secondary insufficiency, with subnormal cortisol peak and low ACTH levels.^[1] Differentiation from secondary causes requires additional testing, such as the CRH stimulation test, which may elicit a modest ACTH response in tertiary cases but is not performed during the standard ACTH test.^[1] An exaggerated cortisol response, with a peak exceeding normal ranges (e.g., >25 mcg/dL or greater than 50% increment), can occur in conditions like early or subclinical Cushing's syndrome due to adrenal hyperplasia or autonomous cortisol secretion, or in states of acute stress that enhance adrenal sensitivity.^[40] Such hyperresponsiveness prompts integration with other diagnostics, including dexamethasone suppression testing or imaging, to guide differential diagnosis of hypercortisolism versus insufficiency.^[40]

Additional Hormone Measurements

In the ACTH stimulation test, measurement of endogenous adrenocorticotropic hormone (ACTH) levels at baseline provides critical diagnostic differentiation between primary and secondary adrenal insufficiency. In primary adrenal insufficiency, baseline endogenous ACTH is typically elevated above 100 pg/mL due to lack of negative feedback from low cortisol production by the adrenal glands.^[41] Conversely, in secondary adrenal insufficiency resulting from pituitary dysfunction, baseline endogenous ACTH levels are low or inappropriately normal, often below 10 pg/mL, reflecting reduced pituitary secretion.^[18] These measurements are obtained via simultaneous blood sampling prior to exogenous ACTH administration, using immunoassays with reference ranges varying by laboratory but generally 10-60 pg/mL for normal morning levels. Aldosterone levels may also be assessed in specific cases during the ACTH stimulation test, particularly to evaluate adrenal zona glomerulosa function in conditions like primary hyperaldosteronism. A normal aldosterone response involves a rise of more than 10 ng/dL from baseline following ACTH stimulation, helping to confirm autonomous aldosterone production when combined with other confirmatory tests such as saline suppression variants.^[42] Baseline aldosterone reference values typically range from 4 to 31 ng/dL in adults under standard conditions (upright posture, normal sodium intake), measured concurrently with cortisol via radioimmunoassay or liquid chromatography-tandem mass spectrometry for accuracy.^[43] In primary adrenal insufficiency, post-stimulation aldosterone may remain low (<5 ng/dL), distinguishing it from secondary forms where zona glomerulosa function is preserved.^[38] Additional analytes, such as dehydroepiandrosterone sulfate (DHEA-S) and 17-hydroxyprogesterone, extend the test's utility for assessing adrenal androgen production and steroidogenesis defects. DHEA-S, a marker of adrenal androgen activity, is measured at baseline and post-stimulation; levels below 25 μg/dL suggest adrenal insufficiency, particularly when cortisol response is indeterminate, as DHEA-S reflects zona reticularis integrity.^[44] In congenital adrenal hyperplasia screening, 17-hydroxyprogesterone levels are evaluated before and 60 minutes after ACTH injection; an exaggerated rise exceeding 1000 ng/dL (30 nmol/L) indicates 21-hydroxylase deficiency, guiding diagnosis of nonclassic forms.^[45] These measurements employ high-performance liquid chromatography or mass spectrometry for precision, with simultaneous sampling protocols ensuring synchronized assessment of multiple hormones to avoid diurnal variations.

Risks and Considerations

Potential Side Effects

The ACTH stimulation test is generally well-tolerated, with most adverse reactions being mild and self-limiting. Common mild effects include facial flushing, nausea, and anxiety, which are reported in some patients and typically resolve within hours without intervention.^[4]^[46] Allergic reactions to synthetic cosyntropin are rare, occurring in less than 1% of cases based on postmarketing reports and case studies, though severe manifestations such as anaphylaxis can occur and require immediate treatment.^[47] Historically, natural ACTH preparations derived from animal sources (e.g., porcine) were associated with a higher incidence of anaphylaxis compared to modern synthetic forms.^[48] Cardiovascular effects, such as transient hypertension or tachycardia, may arise shortly after administration and are more relevant in patients with underlying cardiac conditions, necessitating close monitoring during the procedure.^[49] To manage potential adverse reactions, epinephrine and other emergency treatments for anaphylaxis must be readily available at the testing site, and patients should be observed for at least 30 minutes post-injection to detect and address any delayed symptoms.^[50]

Contraindications and Precautions

The ACTH stimulation test is generally safe with minimal absolute contraindications. The primary absolute contraindication is a known hypersensitivity to cosyntropin (synthetic ACTH) or its components, as this can precipitate severe allergic reactions including anaphylaxis.^[50] Relative contraindications include recent exogenous corticosteroid administration (e.g., hydrocortisone, prednisone), which suppresses the hypothalamic-pituitary-adrenal (HPA) axis and may cause false-normal results; such medications should be withheld for an appropriate period prior to testing when possible.^[1] Another relative contraindication is recent pituitary surgery (within 4-6 weeks), where the test may yield falsely normal cortisol responses due to incomplete adrenal atrophy.^[2] In pregnancy, particularly the first trimester, the test is not absolutely contraindicated but requires cautious interpretation, as elevated cortisol-binding globulin levels can inflate total cortisol measurements without reflecting true adrenal reserve.^[51] Precautions are warranted in patients with cardiovascular conditions, given rare reports of transient hypertension or tachycardia following cosyntropin administration; monitoring vital signs during the test is recommended, though no specific dose adjustments are indicated.^[50] In elderly patients, while the standard dose (250 mcg) remains appropriate, heightened vigilance for adverse effects is advised due to potential comorbidities affecting HPA axis dynamics.^[52] Historically, natural pituitary-derived ACTH was contraindicated in systemic fungal infections owing to cross-reactivity risks, but this does not apply to modern synthetic cosyntropin formulations.^[47] For scenarios where the ACTH stimulation test is unsuitable (e.g., to evaluate central HPA axis function beyond adrenal response), alternatives like the metyrapone test may be employed, though it involves greater risks such as adrenal crisis and requires close monitoring.^[27] Updated clinical guidelines underscore the importance of informed consent, informing patients of potential incidental findings (e.g., subclinical adrenal abnormalities) that could necessitate additional investigations.^[53]

Applications and Future Directions

Use in Veterinary Medicine

The ACTH stimulation test is widely employed in veterinary medicine to evaluate adrenal function in companion animals, most notably for diagnosing hypoadrenocorticism in dogs and cats, which parallels Addison's disease in humans. In dogs, the test is particularly valuable for confirming inadequate cortisol production, with protocols emphasizing synthetic ACTH analogs like cosyntropin to assess adrenocortical reserve.^[54] Standard administration in dogs involves collecting a baseline serum sample followed by intravenous or intramuscular injection of cosyntropin at 5 μg/kg, with a second sample drawn 1 hour post-injection to measure cortisol response. A normal response typically shows post-stimulation cortisol levels of 8.0–20 μg/dL, with an increment of more than 2 μg/dL from baseline indicating adequate adrenal function; values below 2 μg/dL post-stimulation are diagnostic for hypoadrenocorticism. For cats, the protocol uses 5 μg/kg or a fixed dose of 0.125 mg cosyntropin intramuscularly, with baseline and 1-hour post-samples; normal responses exhibit post-stimulation cortisol exceeding 5 μg/dL, while levels below 2 μg/dL suggest adrenal insufficiency. ACTH gel formulations, administered at 2.2 U/kg intramuscularly, serve as an alternative when cosyntropin is unavailable, though they require sampling at 1 and 2 hours due to slower absorption; as of 2025, compounded gels are validated but less preferred due to variability in efficacy.^[55]^[56]^[57]^[58]^[59] Performing the test in veterinary patients presents challenges, including stress from handling, which can artificially elevate baseline cortisol and mimic hyperadrenocorticism, necessitating minimal restraint or mild sedation in fractious animals. Butorphanol increases cortisol responses and should be avoided prior to testing, with effects resolving within 6 hours; dexmedetomidine and trazodone have no significant effects on cortisol and do not require washout.^[60]^[61] In equine practice, the test is adapted to investigate adrenal involvement in conditions like pituitary pars intermedia dysfunction (PPID), often linked to laminitis, using low doses of cosyntropin (0.1–1 μg/kg intravenously) and measuring cortisol at baseline and 30–60 minutes post-administration to assess exaggerated cortisol responses. For exotic species such as ferrets, where adrenal disease manifests as hyperadrenocorticism independent of pituitary control, the ACTH stimulation test is not effective for diagnosis and is not recommended; diagnosis relies on clinical signs, ultrasonography, and hormone panels for sex steroids and 17-hydroxyprogesterone. Recent 2024 veterinary guidelines and studies continue to validate compounded ACTH gel as a cost-effective option for small animal testing, with dosing adjustments to match cosyntropin efficacy in resource-limited settings.^[62]^[63]^[64]^[59]

Emerging Research and Alternatives

Recent validation studies have explored salivary cortisol measurements as a non-invasive alternative to serum sampling during the ACTH stimulation test, demonstrating strong correlations between salivary and serum cortisol levels post-stimulation in patients with suspected adrenal insufficiency.^[65] These approaches aim to improve patient comfort and accessibility, particularly in outpatient settings, by leveraging late-night or stimulated salivary samples to assess adrenal reserve without venipuncture.^[66] Emerging applications of artificial intelligence in endocrinology include machine learning models for analyzing dynamic hormone response curves from stimulation tests, enhancing diagnostic precision by identifying subtle patterns in cortisol trajectories that may indicate early or mild insufficiency.^[67] Such AI tools process serial data to predict outcomes with higher accuracy than traditional thresholds, potentially reducing interpretive variability across assays.^[67] As an alternative for differentiating pituitary from hypothalamic causes of secondary adrenal insufficiency, the corticotropin-releasing hormone (CRH) stimulation test evaluates ACTH responsiveness, offering complementary insights when the standard ACTH test shows blunted cortisol responses.^[16] For autoimmune Addison's disease, detection of 21-hydroxylase autoantibodies serves as a targeted serological alternative, confirming adrenal autoimmunity and guiding risk stratification without functional stimulation.^[68] Ongoing research highlights gaps in understanding long-term outcomes for patients with mild adrenal insufficiency, where subtle cortisol deficiencies may contribute to increased morbidity, including cardiovascular risks and reduced quality of life, despite normal ACTH test results.^[69] Future directions emphasize integrating wearable biosensors for continuous HPA axis monitoring, enabling real-time cortisol profiling through sweat or interstitial fluid analysis to detect stress responses and potentially obviate periodic invasive ACTH testing.^[70] These devices, combining microfluidics with electrochemical detection, could facilitate proactive management of adrenal disorders by tracking dynamic hormone fluctuations over extended periods.^[71]

References

[1]
Adrenocorticotropic Hormone (Cosyntropin) Stimulation Test - NCBI
Cosyntropin stimulation test (CST) is a frequently used dynamic test for the evaluation of the hypothalamus-pituitary-adrenal (HPA) axis in patients ...
[2]
Diagnosis of adrenal insufficiency in adults - UpToDate
The ACTH stimulation test is the best test to diagnose or exclude adrenal insufficiency when the baseline cortisol value is indeterminate. This topic provides ...
[3]
Physiology, Adrenocorticotropic Hormone (ACTH) - StatPearls - NCBI
An ACTH stimulation is a confirmatory test. Exogenous ACTH is administrated while measuring the levels of serum cortisol before administration and 30 minutes ...
[4]
ACTH stimulation test: MedlinePlus Medical Encyclopedia
Aug 28, 2023 · The ACTH stimulation test measures how well the adrenal glands respond to adrenocorticotropic hormone (ACTH). ACTH is a hormone produced in ...Missing: mechanism history
[5]
The utility of the corticotropin test to diagnose adrenal insufficiency ...
Dec 18, 2014 · The corticotropin test was first described using hog pituitary extract as the source of ACTH and assessing changes in plasma cell count and ...
[6]
Diagnosis and Treatment of Primary Adrenal Insufficiency
An ACTH value >66 pmol/L represents a maximum stimulus for cortisol secretion (19, 20). For confirmation, a corticotropin stimulation test should be performed ...Summary of Recommendations · General Introduction · Method of Development of...Missing: indications | Show results with:indications
[7]
Primary Adrenal Insufficiency Guideline Resources
Feb 19, 2016 · The Endocrine Society recommends that acutely ill patients who have unexplained symptoms undergo diagnostic testing to rule out primary adrenal insufficiency.
[8]
Diagnosis and Treatment of Primary Adrenal Insufficiency
PAI was first described by Thomas Addison (1) and is therefore commonly ... ACTH stimulation test. The sensitivity of the high-dose ACTH stimulation ...
[9]
ACTH (Cosyntropin) Stimulation Test - Healthline
Jun 6, 2017 · This ACTH stimulation test measures how your adrenal glands react to the ACTH in your blood. It does this by measuring your body's cortisol levels.
[10]
Challenges in the postsurgical recovery of cushing syndrome
Apr 11, 2024 · Adrenal insufficiency is diagnosed postoperatively by either low basal serum cortisol and/or abnormal cosyntropin stimulation test, and ...
[11]
Adrenal Function After Adrenalectomy for Subclinical ...
As also shown in the paper by Doherty et al (30), the ACTH1–24 test could be a reliable and useful tool to assess the integrity of the HPA axis, even during ...
[12]
Glucocorticoid-induced adrenal insufficiency and glucocorticoid ...
Apr 1, 2024 · The most common cause of adrenal suppression is exogenous steroids, a condition recently termed glucocorticoid-induced adrenal insufficiency ( ...
[13]
Critical illness-related corticosteroid insufficiency (CIRCI) - NIH
Nov 6, 2024 · Endocrine Society recommends that the 250 μg corticotropin stimulation test is the gold standard for diagnosing primary AI (37). The term CIRCI ...
[14]
Critical illness-related corticosteroid insufficiency
Aug 30, 2024 · The Endocrine Society advises stimulatory testing for cortisol deficiency in suspected primary adrenal insufficiency (PAI) cases. Confirmation ...
[15]
Central Adrenal Insufficiency: Etiology and Diagnostic Approach
Corticotropin stimulation tests: The most commonly used test is the corticotropin (synthetic ACTH) stimulation test. The test is based on the fact that ...
[16]
A comparison of low-dose ACTH, glucagon stimulation and insulin ...
In clinical practice, low-dose adrenocorticotrophic hormone (ACTH) stimulation test is a sensitive, safe and easily applicable alternative to ITT. Although it ...Missing: tertiary | Show results with:tertiary
[17]
A Contemporary Approach to the Diagnosis and Management of ...
Jan 22, 2024 · Historically, the insulin tolerance test (ITT) has been widely regarded as the gold standard for diagnosing all forms of AI, particularly those ...
[18]
ACTH (Cosyntropin) Stimulation Test: What It Is & Results
An ACTH (cosyntropin) stimulation test assesses how well your adrenal glands respond to adrenocorticotropic hormone. It can help diagnose adrenal ...
[19]
Low-Dose ACTH (Cosyntropin) Stimulation Test - Together by St. Jude
An ACTH (cosyntropin) stimulation test measures the adrenal gland function and helps diagnose adrenal insufficiency. Learn what to expect from this test.<|control11|><|separator|>
[20]
Free and Total Plasma Cortisol Measured by Immunoassay and ...
Measurement of plasma cortisol by immunoassay after ACTH1–24 stimulation is used to assess the hypothalamic-pituitary-adrenal (HPA) axis.
[21]
CINP - Overview: Cortisol, Mass Spectrometry, Serum
First, the basal plasma ACTH concentration should be measured, and the short cosyntropin stimulation test performed. Cushing syndrome is characterized by ...
[22]
ACTH Stimulation Test for the Diagnosis of Secondary Adrenal ...
Mar 15, 2023 · The low-dose ACTH test is a variation of the standard protocol based on the administration of 1 μg corticotropin for adrenal stimulation.<|control11|><|separator|>
[23]
Reproducibility of the Cortisol Response to Stimulation With the Low ...
Objective: Previous studies have shown that the rapid ACTH stimulation test using a low dose of 1 microg is more sensitive than that using 250 microg ACTH ...Missing: variants | Show results with:variants
[24]
ACTH Stimulation Maximizes the Accuracy of Peripheral Steroid ...
Sep 27, 2021 · Context: Adrenocorticotropic hormone (ACTH) can contribute to aldosterone excess in primary aldosteronism (PA) via increased melanocortin type 2 ...
[25]
Diagnosis and Management of Adrenal Insufficiency - Endotext - NCBI
Aug 20, 2018 · Prolonged ACTH stimulation test; administer 1mg depot Synacthen i.m. or iv infusions 250mcg cosyntropin over 8hrs(A): cortisol/ 24hr urinary ...
[26]
Isolated ACTH Deficiency Confirmed by ACTH Radioimmunoassay
The adrenal glands however produced cortisol normally following prolonged stimulation with depot tetracosactrin. Other anterior pituitary hormones were ...<|control11|><|separator|>
[27]
Plasma aldosterone response to ACTH stimulation test for diagnosis ...
Mar 13, 2024 · The present study examined whether the 1 µg ACTH stimulation test for plasma aldosterone concentration (PAC) can accurately diagnose PA by ...
[28]
H.P. Acthar Gel and Cosyntropin Review: Clinical and Financial ...
Adrenal insufficiency. Cosyntropin may also be less immunogenic than ACTH; amino acids 22 to 39 in ACTH seem to produce most of the molecule's antigenicity. ...
[29]
Cortisol blood test Information | Mount Sinai - New York
Normal values for a blood sample taken at 8 in the morning are 5 to 25 mcg/dL or 138 to 690 nmol/L. Normal values depend on the time of day and the clinical ...
[30]
a comparative analysis using Roche Elecsys Cortisol II ...
Mar 9, 2024 · ElecsysCort II measured mean P-cortisol 9 nmol/L higher compared with LC-MS/MS 30 min post ACTH stimulation, but 4 nmol/L and 35 nmol/L lower ...
[31]
New Cortisol Cutoffs for AI Diagnosis - Endocrine Society
Mar 29, 2021 · The normal cortisol response 30 or 60 minutes after cosyntropin (ACTH[1–24]) is considered to be ≥18 µg/dL (500 nmol/L). This threshold is ...
[32]
ACTH Stimulation Test (Cosyntropin) - Labcorp
ACTH Stimulation Test (Cosyntropin). Purpose: Evaluation of possible primary or secondary adrenal insufficiency, as well as disorders of adrenal steroid ...
[33]
New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency ...
The normal cortisol response 30 or 60 minutes after cosyntropin (ACTH[1–24]) is considered to be ≥18 μg/dL (500 nmol/L). This threshold is based on older ...
[34]
Sex and age differences in cortisol levels during glucagon ...
May 31, 2025 · Girls and younger children had higher peak cortisol at GST. The results support a need for sex- and age-dependent reference values for cortisol.
[35]
Diagnosis of Adrenal Insufficiency & Addison's Disease - NIDDK
The ACTH test may not be accurate in people who have had secondary adrenal insufficiency for a shorter time because their adrenal glands have not yet shrunk and ...
[36]
Primary vs secondary adrenal insufficiency: ACTH-stimulated ...
Once diagnosed with adrenal insufficiency, a stimulated aldosterone value of 5 ng/dl (0·14 nmol/l) works well to differentiate PAI from SAI.Patients And Methods · Known Adrenal Insufficiency · Plasma Acth Values<|control11|><|separator|>
[37]
ACTH Stimulation Test for the Diagnosis of Secondary Adrenal ...
Mar 15, 2023 · The ACTH stimulation test is a safer and well-tolerated tool for SAI diagnosis. However, data about its diagnostic accuracy show great variability.
[38]
Adrenal Incidentalomas with Supraphysiologic Response to ACTH ...
... exaggerated response as well, thus making the diagnosis of CAH unlikely ... Abnormal response to ACTH stimulation test has been shown in patients with major ...
[39]
Atypical presentation of Addison's disease with chest pain and ...
μg/dL combined with a baseline ACTH level > 100 pg/mL will confirm the diagnosis of adrenal insufficiency, while a baseline plasma cortisol > 19 μg/dL will ...
[40]
Hyperaldosteronism Workup - Medscape Reference
Jan 9, 2023 · Plasma aldosterone values higher than 10 ng/dL confirm primary hyperaldosteronism and levels 5-10 ng/dL may be considered borderline. Cortisol ...
[41]
Plasma aldosterone level - Allina Health account
The following are considered to be normal results for this test: Adults: Supine, normal-sodium diet: 2-9 ng/dL (55-250 pmol/L) [5] Upright, normal-sodium diet: ...Missing: baseline | Show results with:baseline
[42]
Primary adrenal insufficiency in adults: When to suspect, how to ...
Sep 1, 2024 · Additionally, Suresh et al reported that a DHEA-S level less than 25 μg/dL confirms adrenal insufficiency, while a level greater than 100 μg/dL ...
[43]
Androgen Excess Workup - Medscape Reference
May 13, 2024 · For this test, 17-hydroxyprogesterone is measured 1 hour after injection of synthetic corticotrophin. levels >10 ng/dL (30.02 nmol/L) are ...
[44]
Cosyntropin as a diagnostic agent in the screening of patients ... - NIH
Cosyntropin is a synthetic derivative of ACTH that is used in the evaluation and diagnosis of patients with adrenocortical insufficiency. Cosyntropin ...
[45]
Cosyntropin (Professional Patient Advice) - Drugs.com
Feb 20, 2025 · Hypersensitivity: Anaphylaxis, hypersensitivity reaction. <1%, postmarketing and/or case reports: Adrenal hemorrhage (Synacthen Depot).
[46]
c206 ACTH (Adrenocorticotrophic hormone) | Allergy & Autoimmune ...
Adverse effects were common when natural ACTH was used, but decreased with the advent of synthetic ACTH peptides such as cosyntropin and tetracosactrin (2).
[47]
Cosyntropin Side Effects: Common, Severe, Long Term - Drugs.com
Nov 21, 2024 · The following adverse reactions have been reported: anaphylaxis, bradycardia, tachycardia, hypertension, peripheral edema, and rash.
[48]
[PDF] cosyntropin injection - accessdata.fda.gov
It has been established that 0.25 mg of cosyntropin injection will stimulate the adrenal cortex maximally and to the same extent as 25 units of natural ACTH.<|control11|><|separator|>
[49]
Assessment of Adrenal Reserve in Pregnancy: Defining the Normal ...
Diagnostic testing is further limited in pregnancy because the insulin tolerance and metyrapone tests are both contraindicated, whereas cortical-releasing ...
[50]
Cosyntropin Dosage Guide + Max Dose, Adjustments - Drugs.com
Jul 16, 2025 · Hypersensitivity to active substance, synthetic ACTH, or any product excipients. Consult WARNINGS section for additional precautions ...
[51]
Pituitary incidentaloma: a Pituitary Society international consensus ...
Jun 24, 2025 · ACTH stimulation testing is recommended to confirm adrenal insufficiency for most patients if morning levels of cortisol are not diagnostic.
[52]
Adrenal Testing in Dogs | College of Veterinary Medicine at MSU
Exogenous corticosteroids can suppress the hypothalamic-pituitary-adrenal axis (HPAA), resulting in adrenal atrophy and subnormal pre- and post-ACTH ...
[53]
[PDF] Submission Guidelines and Test Protocols
a. For dogs, collect baseline serum sample (1.0 ml) then give synthetic ACTH (CortrosynTM) at 5 µg/kg IV (preferred) or IM and collect post-ACTH serum sample ( ...
[54]
Cortisol - ACTH Stimulation Profile - Small Animal (ChL)
Collect pre-ACTH blood sample. · Administer Cosyntropin at 5 µg/kg or 250 µg/dog IV or IM. · Compounded ACTH (gel) can be administered at 2.2 U/kg IM, see ...Missing: protocols | Show results with:protocols
[55]
[PDF] interpretive-guidelines-for-thyroid-and-cortisol-testing-for-dogs-and ...
ACTH stimulation (pre and post) Feline Hypoadrenocorticism: Baseline cortisol < 1 µg/dL and 30 and 60 minute post-cortisol samples < 2 µg/dL are consistent ...
[56]
Feline Adrenal and Pituitary Function Tests
ACTH-Response Test. This test should be used to evaluate adrenocortical function after treatment for hyperadrenocorticism (Cushing's syndrome) and to diagnose ...
[57]
The effects of selected sedatives on basal and stimulated serum ...
Feb 20, 2024 · The adrenocorticotropic hormone (ACTH) stimulation test is commonly used in diagnosis of both hyperadrenocorticism (HAC) and hypoadrenocorticism ...Acth Stimulation And Sample... · Cortisol Assays · Discussion
[58]
ACTH Stimulation Test - an overview | ScienceDirect Topics
The ACTH stimulation test is defined as a diagnostic procedure that involves measuring the cortisol response in horses after administering synthetic ...
[59]
Validation of a low-dose ACTH stimulation test in healthy adult ...
Sep 15, 2011 · Doses of ACTH that have been administered to adult horses range from 2.5 to 2,000 μg/horse or approximately 0.0025 to 4 μg/kg (0.0011 to 1.8 μg/ ...<|separator|>
[60]
State of the union: Ferret adrenocortical disease (Proceedings)
Aug 1, 2009 · The adrenocorticotropic hormone (ACTH) stimulation test and the ... test cannot be used to diagnose adrenal disease in ferrets.
[61]
[PDF] ACTH STIMULATION PROTOCOL DECEMBER 2024 - Squarespace
A recommended protocol for ACTH stimulation test from the European Veterinary Society of. Endocrinology advises a preferred dose of 125 μg/cat. They advocate ...
[62]
Expanding the use of salivary cortisol as a non-invasive outpatient ...
This study demonstrates a good correlation between serum and salivary cortisol levels during the 250 μg synacthen test.
[63]
Utility of Salivary Cortisol and Cortisone in the Diagnostics of ...
The reliability of salivary cortisol compared to serum cortisol for diagnosing adrenal insufficiency with the gold standard ACTH stimulation test in children.
[64]
[PDF] The Integration of Artificial Intelligence in Hormone Analysis
Aug 19, 2025 · Diagnosing growth disorders, such as GH defi- ciency, typically requires stimulation tests and serial sampling to observe the hormone's dynamic ...
[65]
21-Hydroxylase Antibodies - Medscape Reference
Jun 18, 2025 · A positive result for 21-OH Abs indicates autoimmune destruction of the adrenal cortex and is consistent with Addison's disease, either in ...Missing: genomic | Show results with:genomic
[66]
Long‐term corticosteroid use, adrenal insufficiency and the need for ...
Feb 17, 2021 · Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy. Clin Endocrinol (Oxf). 2015; 82: 2–11 ...
[67]
[PDF] Inhibition of Basal and ACTH-Stimulated Cortisol ... - Crinetics
Data shown are mean ± SEM. One subject in 80 mg MAD arm did not receive an ACTH challenge at end of study. Androstenedione (A4).Missing: analogs | Show results with:analogs
[68]
Stressomic: A wearable microfluidic biosensor for dynamic profiling ...
Aug 6, 2025 · The HPA axis triggers cortisol (Cort) release via corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH), while the ...
[69]
Stressomic: A wearable microfluidic biosensor for dynamic profiling ...
Aug 6, 2025 · In this study, we demonstrate the presence of EPI and NE in human sweat and uncover differential dynamic profiles of all three stress hormones ...Results · Hiit Study · Affective Computing With...